PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR), Department of Biochemistry, JSS Academy of Higher Education & Research (JSS AHER), Mysore, 570015 Karnataka, India.\', \'Sechenov First Moscow State Medical University (Sechenov University), St. Trubetskaya, 8, Bld. 2, Moscow 119991, Russia.\', \'AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, 530003 Andhra Pradesh, India.\', \'Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow Region 142432, Russia.\', \'Research Institute of Human Morphology, 3Tsyurupy Street, Moscow 117418, Russia.\', \'GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX 78229, USA.\', \'Special Interest Group in Cancer Biology and Cancer Stem Cells (SIG-CBCSC), JSS Medical College, JSS Academy of Higher Education & Research (JSS AHER), Mysore, 570015 Karnataka, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1155/2021/8160860
?:hasPublicationType
?:journal
  • BioMed research international
is ?:pmid of
?:pmid
?:pmid
  • 34159203
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.935
?:rankingScore_hIndex
  • 82
is ?:relation_isRelatedTo_publication of
?:title
  • The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34159203>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34159203>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all